Project Grant R35GM156435
Award Date
4/21/25
Completion Date
3/31/30
Dollars Obligated
$260K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Colorado, USA
Similar Awards
This $360,100 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports research to develop new pharmaceutical synthetic methods through supramolecular catalysis. The Principal Investigator at the University of California, Berkeley will leverage pioneering work in supramolecular hosts and transition metal catalysis to enable transformations relevant to drug discovery, including...
This $420,000 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to expand the scope of methodologies for chemical probe development toward underexplored biological targets and accelerate drug discovery. The research program has two primary objectives: 1) Improving the throughput of medicinal chemistry through an advanced high-throughput medicinal chemistry (HTMC) platform based on...
The federal Project Grant award R35GM156632, awarded by the National Institute of General Medical Sciences (NIGMS), supports the development of a novel visible light-induced transition metal-radical hybrid catalytic methodology for regiocontrolled, mild, and exogenous oxidant-free functionalizations of saturated groups. The $460,413 award, spanning April 2025 to December 2029, aims to enable selective functionalization of unactivated aliphatic C(sp3)-H bonds, which is a long-standing challenge...
This $1,542,569 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development of new copper-catalyzed reactions for the stereoselective synthesis of chiral amine and ether derivatives, including saturated heterocycles. The objectives include exploring reactions that propagate chirality initiated by enantioselective copper-catalysis, developing a new synthesis of enantioenriched oxygen...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), provides $383,884 to support innovative research that exploits the unique features of radical-mediated migrations to develop new synthetic transformations and catalytic platforms. The research aims to make significant advances in olefin difunctionalizations and stereoselective α-functionalizations of carbonyls, which have...
This federal Project Grant award of $213,563.00 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) with the goal of developing "shapeshifting cyclic peptides" that can behave like multiple drug molecules simultaneously. The grant, awarded to the University of Colorado on September 5, 2024, will fund research to create a new class of adaptable molecules that can assume a wide array of...
This Project Grant award of $371,371.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development and application of reactions to enable molecular rigidification. The award will fund a research program focused on developing reactions to access rigid small and medium-sized strained rings, using sulfone anions as carbene surrogates and new methods to stabilize reactive alkylidene units through...
The National Institute of General Medical Sciences (NIGMS) has awarded a $385,298 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Stony Brook University, a prominent research institution, to develop new methods for synthesizing complex primary amines from simple amino acids. The overarching 5-year goal is to establish a novel biomimetic organic synthesis approach that leverages rationally designed pyridoxal-5'-phosphate (PLP)-mimicking catalysts to enable open-shell...
The National Institute of General Medical Sciences (NIGMS) awarded a $390,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Texas at Dallas. The grant, which runs from August 1, 2024 to May 31, 2029, supports the development of new chemical methods and synthesis strategies to enable reliable access to complex bioactive natural and unnatural compounds. This research aims to advance the synthesis of polycyclic molecular frameworks with...
The National Institute of General Medical Sciences (NIGMS) has awarded a $328,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to The University of Texas Southwestern Medical Center. This 5-year grant, spanning from August 2024 to May 2029, will fund research aimed at developing new tools and strategies to synthesize highly complex natural products that can serve as the basis for novel medicines. The research will focus on two key complexity-building...